Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: losses through Phoenix

losses through Phoenix

posted on Oct 11, 2007 06:21AM

I didn't know PTSC could occur losses through Phoenix.

(taken from 10Q)

The quarterly results included $1.2 million as the company's share of the net loss of Phoenix Digital Solutions, the joint venture entity that is owned half by Patriot Scientific and half by The TPL Group. Phoenix Digital receives its income from licenses purchased by manufacturers who use technologies contained in the MMP Patent Portfolio.

During the three months ended August 31, 2007 the company had incurred a net loss of $1.96 million or $0.01 per diluted share. During this period Phoenix Digital entered into technology licensing agreements with aggregate proceeds of $1.5 million. The dollar amount for each licensing deal varies, depending upon factors that include, among other things, the relevance of the patents to each licensee's revenue and the extent to which the patented technology is incorporated into specific products.

I may be naieve. But I still think PTSC's future looks bright and I'm still waiting for my pot of gold.

Share
New Message
Please login to post a reply